Albany, NY -- (SBWIRE) -- 08/16/2018 -- A recent market research report by Transparency Market Research observes that the global market for orphan diseases testing has gathered pace as a number of new companies are foraying into the field. Vast technological development in the field of genomics and the availability of several patient-specific treatments are also driving the market, states the report. The report is titled "Orphan Diseases Testing Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017–2025."
Read Report Overview @ https://www.transparencymarketresearch.com/orphan-diseases-testing-market.html
The market has also benefitted recently from the increased adoption of genetic screening in children for the diagnosis of hereditary diseases early on in their lives. This trend is also expected to emerge as a top contributor to the growth prospects of the global orphan diseases testing market over the period between 2017 and 2025. The report also includes an analysis of other key growth drivers, restraints, and trends affecting the overall growth prospects of the market.
The report segments the global orphan diseases testing market based on categories such as technology, disease type, end-user, and geography. On the basis of the type of disease, the market is segmented into Lou Gehrig's disease, cystic fibrosis, and Tourette's syndrome. On the basis of technology, the report covers the market for orphan diseases testing into RT-PCR, genetic analyzers, NGS platforms, and microarrays.
Obtain the Report Brochure @ https://www.transparencymarketresearch.com/sample/sample.php?flag=B&rep_id=41153
On the basis of end-user, the report segments the global orphan diseases testing market into diagnostic centers, academic and research institutes, and others. The vast rise in research and development activities in the healthcare industry in the past few years, which use gene sequencing technologies for the diagnosis of orphan diseases, is expected to play a key role in the development of the orphan diseases testing market in the next few years.
Geographically, the market for orphan disease testing has been covered in the report for regions such as Latin America, Asia Pacific, Europe, North America, and Middle East and Africa. Of these, the market in North America accounted for the dominant share in the overall market in 2016, thanks to the presence of some of the most influential players in the field in the region and a vast surge in R&D practices in the past few years. The market in Asia Pacific is expected to benefit from the increased awareness regarding orphan diseases and the need for proper diagnosis.
Request for Report TOC @ https://www.transparencymarketresearch.com/sample/sample.php?flag=T&rep_id=41153
The market for orphan disease testing has witnessed the foray of several new companies in the past few years as governments and non-government organizations have surged ahead with funds and encouraging regulations to foster developments in the field. The vendor landscape has thus become heated and dynamic. Some of the leading companies in the market are Bio-Rad Laboratories, Inc., Illumina, Inc., and Thermo Fisher Scientific, Inc.
About Transparency Market Research
Transparency Market Research is a global market intelligence company, providing global business information reports and services. Our exclusive blend of quantitative forecasting and trends analysis provides forward-looking insight for thousands of decision makers. Our experienced team of Analysts, Researchers, and Consultants, use proprietary data sources and various tools and techniques to gather, and analyze information.
Our data repository is continuously updated and revised by a team of research experts, so that it always reflects the latest trends and information. With a broad research and analysis capability, Transparency Market Research employs rigorous primary and secondary research techniques in developing distinctive data sets and research material for business reports.